IL32 and rheumatoid arthritis: Future studies should focus on longitudinal evaluations that compare IL-32 levels in RA with those in other inflammatory disorders to determine whether its predictive value is indeed specific to RA-related CV complications or reflects a more generalized inflammatory state.